For laboratory research use only — not for human or veterinary use. Not evaluated by the U.S. FDA.
GH Secretagogue Peptide
Sermorelin
The first 29 amino acids of growth-hormone-releasing hormone — the shortest fragment retaining full activity — studied in research models for GHRH receptor signaling.
Size
Quantity
$24.99
Bundle & save
Delivery
Order by 3:00 PM ET for same-day dispatch
Cutoff 3:00 PM ET · same-day dispatch
Estimated arrival in 2–3 business days
Overnight shipping available
Free shipment protection included
Sermorelin
1 × 2mg · $24.99
99% purity, QC passed
HPLC + mass-spec verified
Shipment protection
Free on every order
Free shipping over $150
Same-day dispatch before 3PM ET
Certificate of Analysis
Third-party tested · Independent analytical lab
5mg
98.78%latest
| Tested | Measured | Purity |
|---|---|---|
| Jun 2026 | 5.39mg | 98.78% |
| Apr 2026 | 5.56mg | 99.31% |
| Feb 2026 | 5.70mg | 99.34% |
| Jan 2026 | 5.50mg | 99.41% |
| Nov 2025 | 5.62mg | 99.01% |
Frequently researched together
Commonly studied alongside Sermorelin.
Compound information
Technical specifications
Molecular profile
| Type | GHRH (1-29) analog |
| CAS number | 114466-38-5 |
| Molecular weight | 3357.9 g/mol |
| Amino acids | 29 |
| Formula | C149H246N44O42S |
Storage & stability
- ❄️
Lyophilized (powder)
-20°C · stable 2+ years
- ❄️
Reconstituted
2–8°C · use within 30 days
Sources & references
Peer-reviewed literature, for research context
- Clinical interventions in aging
Sermorelin: a better approach to management of adult-onset growth hormone insufficiency?
2006·DOI: 10.2147/ciia.2006.1.4.307·PMID: 18046908Walker RF
View source - BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency
1999·DOI: 10.2165/00063030-199912020-00007·PMID: 18031173Prakash A, Goa KL
View source - Clinical endocrinology
Treatment of radiation-induced growth hormone deficiency with growth hormone-releasing hormone
1997·DOI: 10.1046/j.1365-2265.1997.1790998.x·PMID: 9231053Ogilvy-Stuart AL, Stirling HF, Kelnar CJ, Savage MO, Dunger DB, Buckler JM
View source - Acta paediatrica (Oslo, Norway : 1992). Supplement
Growth response to growth hormone-releasing hormone(1-29)-NH2 compared with growth hormone
1993·DOI: 10.1111/j.1651-2227.1993.tb12828.x·PMID: 8329826Neyzi O, Yordam N, Ocal G, Bundak R, Darendeliler F, Açikgöz E
View source
Important research notice
Not for human consumption. This product is sold exclusively for laboratory and in vitro research. It is not intended to diagnose, treat, cure, or prevent any disease.
Any research findings referenced on this page are drawn from published, peer-reviewed literature and are provided for educational context only. They are not product claims and should not be read as medical advice.
By purchasing, you confirm you are a qualified researcher and will handle this material in accordance with all applicable laws and institutional guidelines.